Your Messege:
Your Name:(Required)
 
Email Address:(Required)
 
Message:
 
 

FORUM
To view the weather click here.
Moxifloxacin prophylaxis against MDR TB Moxifloxacin prophylaxis against MDR TB
The study demonstrate that contacts of persons infected with multidrug–resistant tuberculosis (MDR TB) have few prophylaxis options.
2015/2/22
Characteristics of tuberculosis cases that started outbreaks in the United States, 2002-2011 Characteristics of tuberculosis cases that started outbreaks in the United States, 2002-2011
A CDC analysis of the initial cases leading to 26 tuberculosis (TB) outbreaks in the U.S. found many common characteristics among the source patients, including long infectious periods and several social risk factors
2015/2/22
Epidemiology of human mycobacterium bovis disease, california, USA, 2003-2011 Epidemiology of human mycobacterium bovis disease, california, USA, 2003-2011
Researchers express that M. Bovis TB in California has increased, exceeding the national average.
2015/2/22
Immune Biomarkers Help Predict Early Death, Complications in HIV Patients with TB Immune Biomarkers Help Predict Early Death, Complications in HIV Patients with TB
Medical researchers have identified immune biomarkers in HIV/TB patients before they begin Antiretroviral therapy (ART) that could help distinguish who goes on to develop Immune Reconstitution Inflammatory Syndrome (IRIS) or die after treatment.
2015/2/12
Potential for inhalable vaccines for Tuberculosis, influenza, pneumonia, with new approach Potential for inhalable vaccines for Tuberculosis, influenza, pneumonia, with new approach
Researchers to creating inhalable vaccines using nanoparticles that shows promise for targeting lung-specific diseases, such as influenza, pneumonia and tuberculosis.
2015/2/12
Antibiotic breakthrough may signal the end of drug-resistant superbugs Antibiotic breakthrough may signal the end of drug-resistant superbugs
Scientists have come across a potential game-changer in the fight against drug-resistant superbugs - a new class of antibiotic that is resistant to resistance.
2015/2/12
Antiangiogenesis drugs could make major improvement in tuberculosis treatment Antiangiogenesis drugs could make major improvement in tuberculosis treatment
Use of the same antiangiogenesis drugs that have improved treatment of some cancers could also help surmount persistent difficulties in treating tuberculosis, improving the effectiveness of drug therapy and reducing the emergence of resistant bacterial strains.
2015/2/4
Identifying Zombie Bacteria May Help Treat TB Identifying Zombie Bacteria May Help Treat TB
“Living-dead” bacteria exist in limbo state; which is biologically active but not proliferating.
2015/2/4
Elucidating the origin of MDR tuberculosis strains Elucidating the origin of MDR tuberculosis strains
A study has focused on the evolutionary history of the mycobacterium that causes tuberculosis, and more specifically on the Beijing lineage associated with the spread of multidrug resistant forms of the disease in Eurasia.
2015/2/4
Efficient, validated method for the detection of mycobacterial growth in liquid culture media using bead-beating, magnetic particle nucleic acid isolation and quantitative PCR. Efficient, validated method for the detection of mycobacterial growth in liquid culture media using bead-beating, magnetic particle nucleic acid isolation and quantitative PCR.
Since pathogenic mycobacteria such as Mycobacterium avium subsp. Paratuberculosis (MAP) are difficult to culture, requiring specialised media and a long incubation time, and have complex and exceedingly robust cell walls, this study reports an efficient DNA isolation and quantitative PCR methodology for the specific detection ...
2015/2/4
Evaluation of the Speed-Oligo® Mycobacteria assay for the identification of nontuberculous mycobacteria. Evaluation of the Speed-Oligo® Mycobacteria assay for the identification of nontuberculous mycobacteria.
The Speed-Oligo® Mycobacteria assay is an oligochromatographic method that was made available recently for the identification and differentiation of mycobacteria It can be a useful tool for the rapid and easy identification of the most common NTM
2015/2/4
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients. Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients.
Mycobacterium avium subspecies paratuberculosis (MAP) is associated with MS in Sardinia
2015/2/4
Tuberculosis: a new way of improving treatment rejected Tuberculosis: a new way of improving treatment rejected
In 2003, a new antibiotic from the fluoroquinolone family – gatifoxacin was provided for four months treatment of Tuberculosis, instead of the six months required with the current standard combination therapy
2015/1/28
New whole blood assay may help overcome roadblocks to TB eradication New whole blood assay may help overcome roadblocks to TB eradication
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI).
2015/1/28
Emergency medical support needed to prevent deaths in Donetsk and Luhansk Emergency medical support needed to prevent deaths in Donetsk and Luhansk
Concerns are growing over the disruption in treatment for people living with HIV and tuberculosis in Donetsk and Luhansk which have interrupted crucial medical supplies
2015/1/28
Join The AASM
AASM log in page
Membership fee
Contact us
Links
2015 Mar 5
Last changed   2015/2/22
Webmaster manager@theaasm.org

Did you know that Aboalis Avicenne (980-1037)

was the first doctor who described three stages

for tuberculosis.  In his book

Canin  de La Medicine he named them as :

*.Stade de preinflammatoire

*.Stade de ulcere rongeant

*.Stade de Caverne


Copyright © 2011 AASM. All Rights Reserved.